Exploits Discovery Corp. (CSE:NFLD)

MorphoSys AG Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Net Income	-4.46	-4.72	-9.53	-7.66	-7.56	-10.4
Depreciation & Amortization	0.79	0.79	2.86	0.01	0.42	0.01
Loss (Gain) From Sale of Investments	-0.02	-0.01	0.03	0.06	0.53	-0.42
Stock-Based Compensation	0.18	0.22	0.29	0.23	0.57	2.2
Other Operating Activities	-0.43	-0.37	-1.04	-1.15	-0.61	-0.19
Change in Accounts Payable	-0.09	0.02	-1.06	-1.31	0.47	0.22
Change in Income Taxes	0.06	0.02	0.21	0.34	0.35	-0.82
Change in Other Net Operating Assets	0.1	0.08	-0.09	-0.05	-0.02	0.15
Operating Cash Flow	-3.87	-3.98	-8.33	-9.51	-5.83	-9.26
Capital Expenditures	-0.1	-0.1	-0.07	-0.08	-0.06	-0.63
Investment in Securities	-	0.04	-	-	-	-0.08
Other Investing Activities	0.01	0.02	0.87	0.67	-1.05	-
Investing Cash Flow	-0.09	-0.04	0.8	0.59	-1.11	-0.71
Issuance of Common Stock	1.6	1.6	5.8	4.42	4.5	19.96
Other Financing Activities	-0.03	-0.03	-0.26	-0.15	-0.15	-0.3
Financing Cash Flow	1.57	1.57	5.54	4.27	4.35	19.67
Net Cash Flow	-2.39	-2.45	-1.98	-4.66	-2.59	9.7
Free Cash Flow	-3.96	-4.07	-8.39	-9.59	-5.9	-9.88
Free Cash Flow Per Share	-0.02	-0.03	-0.06	-0.07	-0.05	-0.12
Levered Free Cash Flow	-	-1.96	-	-6.12	-2.67	-4.68
Unlevered Free Cash Flow	-	-1.96	-	-6.12	-2.67	-4.68

Updated Nov 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.